المؤلفون: S. V. Kotov, R. I. Guspanov, A. G. Yusufov, A. A. Nemenov, A. A. Mantsov, С. В. Котов, Р. И. Гуспанов, А. Г. Юсуфов, А. А. Неменов, А. А. Манцов

المساهمون: The study was not sponsored., Исследование не имело спонсорской поддержки

المصدر: Urology Herald; Том 11, № 2 (2023); 47-55 ; Вестник урологии; Том 11, № 2 (2023); 47-55 ; 2308-6424 ; 10.21886/2308-6424-2023-11-2

مصطلحات موضوعية: adherent perinephric fat [спаечная жировая клетчатка], kidney tumour, laparoscopic partial nephrectomy, Mayo Adhesive Probability score, adherent perinephric fat, опухоль почки, лапароскопическая резекция почки, Mayo Adhesive Probability score [оценка вероятности адгезии по Mayo]

وصف الملف: application/pdf

Relation: https://www.urovest.ru/jour/article/view/719/465; Volpe A. The role of active surveillance of small renal masses. Int J Surg. 2016;36(Pt C):518-524. DOI:10.1016/j.ijsu.2016.06.007; Kriegmair MC, Mandel P, Moses A, Lenk J, Rothamel M, Budjan J, Michel MS, Wagener N, Pfalzgraf D. Defining Renal Masses: Comprehensive Comparison of RENAL, PADUA, NePhRO, and C-Index Score. Clin Genitourin Cancer. 2017;15(2):248-255.e1. DOI:10.1016/j.clgc.2016.07.029; Xiao Y, Shan ZJ, Yang JF, Len JJ, Yu YH, Yang ML. Nephrometric scoring system: Recent advances and outlooks. Urol Oncol. 2023;41(1):15-26. DOI:10.1016/j.urolonc.2022.06.019; Veccia A, Antonelli A, Uzzo RG, Novara G, Kutikov A, Ficarra V, Simeone C, Mirone V, Hampton LJ, Derweesh I, Porpiglia F, Autorino R. Predictive Value of Nephrometry Scores in Nephron-sparing Surgery: A Systematic Review and Meta-analysis. Eur Urol Focus. 2020;6(3):490-504. DOI:10.1016/j.euf.2019.11.004; Macleod LC, Hsi RS, Gore JL, Wright JL, Harper JD. Perinephric fat thickness is an independent predictor of operative complexity during robot-assisted partial nephrectomy. J Endourol. 2014;28(5):587-91. DOI:10.1089/end.2013.0647; Hagiwara M, Miyajima A, Hasegawa M, Jinzaki M, Kikuchi E, Nakagawa K, Oya M. Visceral obesity is a strong predictor of perioperative outcome in patients undergoing laparoscopic radical nephrectomy. BJU Int. 2012;110(11 Pt C):E980-4. DOI:10.1111/j.1464-410X.2012.11274.x; Lee SM, Robertson I, Stonier T, Simson N, Amer T, Aboumarzouk OM. Contemporary outcomes and prediction of adherent perinephric fat at partial nephrectomy: a systematic review. Scand J Urol. 2017;51(6):429-434. DOI:10.1080/21681805.2017.1357656; Davidiuk AJ, Parker AS, Thomas CS, Leibovich BC, Castle EP, Heckman MG, Custer K, Thiel DD. Mayo adhesive probability score: an accurate image-based scoring system to predict adherent perinephric fat in partial nephrectomy. Eur Urol. 2014;66(6):1165-71. DOI:10.1016/j.eururo.2014.08.054; Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. DOI:10.3322/caac.21492; Herr HW. A history of partial nephrectomy for renal tumors. J Urol. 2005;173(3):705-8. DOI:10.1097/01.ju.0000146270.65101.1d; Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, Faraday MM, Kaouk JH, Leveillee RJ, Matin SF, Russo P, Uzzo RG; Practice Guidelines Committee of the American Urological Association. Guideline for management of the clinical T1 renal mass. J Urol. 2009;182(4):1271-9. DOI:10.1016/j.juro.2009.07.004; Choi JE, You JH, Kim DK, Rha KH, Lee SH. Comparison of perioperative outcomes between robotic and laparoscopic partial nephrectomy: a systematic review and meta-analysis. Eur Urol. 2015;67(5):891-901. DOI:10.1016/j.eururo.2014.12.028; Lin P, Wu M, Gu H, Tu L, Liu S, Yu Z, Chen Q, Liu C. Comparison of outcomes between laparoscopic and robot-assisted partial nephrectomy for complex renal tumors: RENAL score ≥7 or maximum tumor size >4 cm. Minerva Urol Nephrol. 2021;73(2):154-164. DOI:10.23736/S2724-6051.20.04135-1; Sharma G, Sharma AP, Tyagi S, Bora GS, Mavuduru RS, Devana SK, Singh SK. Robot-assisted partial nephrectomy for moderate to highly complex renal masses. A systematic review and meta-analysis. Indian J Urol. 2022;38(3):174-183. DOI:10.4103/iju.iju_393_21; Kocher NJ, Kunchala S, Reynolds C, Lehman E, Nie S, Raman JD. Adherent perinephric fat at minimally invasive partial nephrectomy is associated with adverse peri-operative outcomes and malignant renal histology. BJU Int. 2016;117(4):636-41. DOI:10.1111/bju.13378; Fang L, Li H, Zhang T, Liu R, Zhang T, Bi L, Xie D, Wang Y, Yu D. Analysis of predictors of adherent perinephric fat and its impact on perioperative outcomes in laparoscopic partial nephrectomy: a retrospective case-control study. World J Surg Oncol. 2021;19(1):319. DOI:10.1186/s12957-021-02429-6; Сирота Е.С., Рапопорт Л.М., Гридин В. Н., Цариченко Д.Г., Кузнецов И.А., Сирота А.Е., Аляев Ю.Г. Анализ кривой обучения хирургов в зависимости от сложности нефрометрической оценки при выполнении лапароскопической резекции почки у пациентов с локализованными образованиями паренхимы почки. Урология. 2020;6:11-18. DOI:10.18565/urology.2020.6.11-18; Sempels M, Ben Chehida MA, Meunier P, Waltregny D. Open and Laparoscopic Partial Nephrectomy: Comparison and Validation of Preoperative Scoring Systems, Including PADUA, RENAL, ABC Nephrometric Scores and Perinephric Fat Evaluation with Mayo Adhesive Probability Score. Res Rep Urol. 2021;13:509-517. DOI:10.2147/RRU.S293864; https://www.urovest.ru/jour/article/view/719

الاتاحة: https://www.urovest.ru/jour/article/view/719
https://doi.org/10.21886/2308-6424-2023-11-2-47-55

المؤلفون: M. Y. Gaas, A. D. Kaprin, N. V. Vorobyev, R. O. Inozemtsev, A. G. Rerberg, М. Я. Гаас, А. Д. Каприн, Н. В. Воробьев, Р. О. Иноземцев, А. Г. Рерберг

المصدر: Siberian journal of oncology; Том 22, № 4 (2023); 84-93 ; Сибирский онкологический журнал; Том 22, № 4 (2023); 84-93 ; 2312-3168 ; 1814-4861

مصطلحات موضوعية: интрасинусная опухоль почки, selective “intra-arterial” cold ischemia, laparoscopic partial nephrectomy, intrasinus tumor of the kidney, селективная «внутриартериальная» холодовая ишемия, лапароскопическая резекция почки

وصف الملف: application/pdf

Relation: https://www.siboncoj.ru/jour/article/view/2682/1141; Van Poppel H., Da Pozzo L., Albrecht W., Matveev V., Bono A., Borkowski A., Colombel M., Klotz L., Skinner E., Keane T., Marreaud S., Collette S., Sylvester R. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephronsparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2011; 59(4): 543–52. doi:10.1016/j.eururo.2010.12.013.; Zhang Z., Zhao J., Zabell J., Remer E., Li J., Campbell J., Dong W., Palacios D.A., Patel T., Demirjian S., Campbell S.C. Proteinuria in Patients Undergoing Renal Cancer Surgery: Impact on Overall Survival and Stability of Renal Function. Eur Urol Focus. 2016; 2(6): 616–22. doi:10.1016/j.euf.2016.01.003.; Mir M.C., Ercole C., Takagi T., Zhang Z., Velet L., Remer E.M., Demirjian S., Campbell S.C. Decline in renal function after partial nephrectomy: etiology and prevention. J Urol. 2015; 193(6): 1889–98. doi:10.1016/j.juro.2015.01.093.; Mir M.C., Campbell R.A., Sharma N., Remer E.M., Simmons M.N., Li J., Demirjian S., Kaouk J., Campbell S.C. Parenchymal volume preservation and ischemia during partial nephrectomy: functional and volumetric analysis. Urology. 2013; 82(2): 263–8. doi:10.1016/j.urology.2013.03.068. Erratum in: Urology. 2013; 82(5): 1195.; Simmons M.N., Hillyer S.P., Lee B.H., Fergany A.F., Kaouk J., Campbell S.C. Functional recovery after partial nephrectomy: efects of volume loss and ischemic injury. J Urol. 2012; 187(5): 1667–73. doi:10.1016/j.juro.2011.12.068.; Воробьев Н.В., Рерберг А.Г., Рябов А.Б., Мурадян А.Г, Болотова Р.С., Каприн А.Д., Тараки Х. Способ антиишемической защиты паренхимы почки при лапароскопической резекции. Патент РФ № 2793505. Заявл. 10.06.2022; Опубл. 04.04.2023.; Zabell J.R., Wu J., Suk-Ouichai C., Campbell S.C. Renal Ischemia and Functional Outcomes Following Partial Nephrectomy. Urol Clin North Am. 2017; 44(2): 243–55. doi:10.1016/j.ucl.2016.12.010.; Thompson R.H., Lane B.R., Lohse C.M., Leibovich B.C., Fergany A., Frank I., Gill I.S., Blute M.L., Campbell S.C. Renal function after partial nephrectomy: efect of warm ischemia relative to quantity and quality of preserved kidney. Urology. 2012; 79(2): 356–60. doi:10.1016/j.urology.2011.10.031.; Lane B.R., Russo P., Uzzo R.G., Hernandez A.V., Boorjian S.A., Thompson R.H., Fergany A.F., Love T.E., Campbell S.C. Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifable factors in determining ultimate renal function. J Urol. 2011; 185(2): 421–7. doi:10.1016/j.juro.2010.09.131.; Mir M.C., Takagi T., Campbell R.A., Sharma N., Remer E.M., Li J., Demirjian S., Stein R., Kaouk J., Campbell S.C. Poorly functioning kidneys recover from ischemia after partial nephrectomy as well as strongly functioning kidneys. J Urol. 2014; 192(3): 665–70. doi:10.1016/j.juro.2014.03.036.; Yossepowitch O., Eggener S.E., Serio A., Huang W.C., Snyder M.E., Vickers A.J., Russo P. Temporary renal ischemia during nephron sparing surgery is associated with short-term but not long-term impairment in renal function. J Urol. 2006; 176(4 Pt 1): 1339–43. doi:10.1016/j.juro.2006.06.046.; Takagi T., Mir M.C., Campbell R.A., Sharma N., Remer E.M., Li J., Demirjian S., Kaouk J.H., Campbell S.C. Predictors of precision of excision and reconstruction in partial nephrectomy. J Urol. 2014; 192(1): 30–5. doi:10.1016/j.juro.2013.12.035.; Secin F.P. Importance and limits of ischemia in renal partial surgery: experimental and clinical research. Adv Urol. 2008. doi:10.1155/2008/102461.; Zhang Z., Zhao J., Velet L., Ercole C.E., Remer E.M., Mir C.M., Li J., Takagi T., Demirjian S., Campbell S.C. Functional Recovery From Extended Warm Ischemia Associated With Partial Nephrectomy. Urology. 2016; 87: 106–13. doi:10.1016/j.urology.2015.08.034.; Volpe A., Blute M.L., Ficarra V., Gill I.S., Kutikov A., Porpiglia F., Rogers C., Touijer K.A., Van Poppel H., Thompson R.H. Renal Ischemia and Function After Partial Nephrectomy: A Collaborative Review of the Literature. Eur Urol. 2015; 68(1): 61–74. doi:10.1016/j.eururo.2015.01.025.; Parekh D.J., Weinberg J.M., Ercole B., Torkko K.C., Hilton W., Bennett M., Devarajan P., Venkatachalam M.A. Tolerance of the human kidney to isolated controlled ischemia. J Am Soc Nephrol. 2013; 24(3): 506–17. doi:10.1681/ASN.2012080786.; Simmons M.N., Lieser G.C., Fergany A.F., Kaouk J., Campbell S.C. Association between warm ischemia time and renal parenchymal atrophy after partial nephrectomy. J Urol. 2013; 189(5): 1638–42. doi:10.1016/j.juro.2012.11.042.; Zhang Z., Ercole C.E., Remer E.M., Mir M.C., Takagi T., Velet L., Li J., Zhao J., Demirjian S., Campbell S.C. Analysis of Atrophy After Clamped Partial Nephrectomy and Potential Impact of Ischemia. Urology. 2015; 85(6): 1417–22. doi:10.1016/j.urology.2015.02.040.; Choi K.H., Yoon Y.E., Kim K.H., Han W.K. Contralateral kidney volume change as a consequence of ipsilateral parenchymal atrophy promotes overall renal function recovery after partial nephrectomy. Int Urol Nephrol. 2015; 47(1): 25–32. doi:10.1007/s11255-014-0847-2.; Ackermann D., Lenzin A., Tscholl R. Renale Hypothermie in situ. Vergleich zwischen Oberfächen- und Perfusionskühlung hinsichtlich der Nierenfunktion im späteren postoperativen Verlauf beim Schwein [Renal hypothermia in situ. Comparison between surface and perfusion cooling concerning renal function in pigs (author’s transl)]. Urologe A. 1979; 18(1): 38–43. German.; Wagenknecht L.V., Hupe W., Bücheler E., Klosterhalfen H. Selective hypothermic perfusion of the kidney for intrarenal surgery. Eur Urol. 1977; 3(2): 62–8. doi:10.1159/000472060.; Morishita K., Yokoyama H., Inoue S., Koshino T., Tamiya Y., Abe T. Selective visceral and renal perfusion in thoracoabdominal aneurysm repair. Eur J Cardiothorac Surg. 1999; 15(4): 502–7. doi:10.1016/s1010-7940(99)00075-5.; Janetschek G., Abdelmaksoud A., Bagheri F., Al-Zahrani H., Leeb K., Gschwendtner M. Laparoscopic partial nephrectomy in cold ischemia: renal artery perfusion. J Urol. 2004; 171(1): 68–71. doi:10.1097/01.ju.0000101040.13244.c4.; https://www.siboncoj.ru/jour/article/view/2682

الاتاحة: https://www.siboncoj.ru/jour/article/view/2682
https://doi.org/10.21294/1814-4861-2023-22-4-84-93

المؤلفون: V. R. Latypov, O. S. Popov, V. N. Latypova, D. B. Akhmedov, O. S. Zebzeeva, В. Р. Латыпов, О. С. Попов, В. Н. Латыпова, Д. Б. Ахмедов, О. С. Зебзеева

المصدر: Cancer Urology; Том 19, № 2 (2023); 89-93 ; Онкоурология; Том 19, № 2 (2023); 89-93 ; 1996-1812 ; 1726-9776

مصطلحات موضوعية: редкая опухоль почки, composite hemangioendothelioma, rare kidney tumor, композитная гемангиоэндотелиома

وصف الملف: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1567/1461; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1567/1132; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1567/1133; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1567/1134; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1567/1135; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1567/1136; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1567/1137; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1567/1138; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1567/1139; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1567/1140; EAU Guidelines on Renal Cell Carcinoma. European Association of Urology, 2021.; Renal cell carcinomas comprise a broad spectrum of histopathological entities described in the 2016 World Health Organization (WHO) classification.; Nayler S.J., Rubin B.P., Calonje E. et al. Composite hemangioendothelioma: a complex, low-grade vascular lesion mimicking angiosarcoma. Am J Surg Pathol 2000;24(3):352–61. DOI:10.1097/00000478-200003000-00003; McNab P.M., Quigley B.C., Glass L.F., Jukic D.M. Composite hemangioendothelioma and its classification as a low-grade malignancy. Am J Dermatopathol 2013;35(4):517–22. DOI:10.1097/DAD.0b013e31827a0d37; Stojsic Z., Brasanac D., Stojanovic M., Boricic M. Cutaneous composite hemangioendothelioma: case report and review of published reports. Ann Saudi Med 2014;34(2):182–8. DOI:10.5144/0256-4947.2014.182; Chin S., Kim J., Jung M. et al. Intramuscular composite hemangioendothelioma: case report of an unusual tumor in an unusual location. Int J Clin Exp Pathol 2020;13(6):1421–5.; Umar A.K., Suleiman D.E. Composite hemangioendothelioma of the scalp: an unusual presentation of a rare vascular tumor of low malignant potential. Arch Int Surg 2017;7(4).; Gok S., Berkman M.Z., Baykara E. Composite hemangioendothelioma settled in the paraspinal region: a rare case report. Turk Neurosurg 2020;30(2):299–302. DOI:10.5137/1019-5149.JTN.22256-17.4; Bhat A., Chowdappa V. Composite hemangioendothelioma: report of a rare case. J Clin Diagnc Res 2016;10(10):ED01–3. DOI:10.7860/JCDR/2016/19994.8602; Li W.W., Liang P., Zhao H.P. et al Composite hemangioendothelioma of the spleen with multiple metastases: CT findings and review of the literature. Medicine (Baltimore) 2021;100(21):e25846. DOI:10.1097/MD.0000000000025846; Langguth P., Ravesh M.S., Haneya A. et al Composite hemangioendothelioma: the first case of a right atrioventricular pericardial tumour. Eur Heart J Case Rep 2020;4(3):1. DOI:10.1093/ehjcr/ytaa110; Zhang J., Wu B., Zhou G.Q. et al. Composite hemangioendothelioma arising from the kidney: case report with review of the literature. Int J Clin Exp Pathol 2013;6(9):1935–41.; https://oncourology.abvpress.ru/oncur/article/view/1567

الاتاحة: https://oncourology.abvpress.ru/oncur/article/view/1567
https://doi.org/10.17650/1726-9776-2023-19-2-89-93

المؤلفون: E. V. Lomonosova, A. B. Golbits, N. A. Rubtsova, B. Ya. Alekseev, A. D. Kaprin, Е. В. Ломоносова, А. Б. Гольбиц, Н. А. Рубцова, Б. Я. Алексеев, А. Д. Каприн

المصدر: Medical Visualization; Том 27, № 2 (2023); 85-98 ; Медицинская визуализация; Том 27, № 2 (2023); 85-98 ; 2408-9516 ; 1607-0763

مصطلحات موضوعية: количественная оценка функции почки, renal tumor, partial nephrectomy, vascular renal diseases, obstructive uropathy, estimated renal function, опухоль почки, резекция почки, сосудистые заболевания почек, обструктивная уропатия

وصف الملف: application/pdf

Relation: https://medvis.vidar.ru/jour/article/view/1220/793; https://medvis.vidar.ru/jour/article/downloadSuppFile/1220/1991; https://medvis.vidar.ru/jour/article/downloadSuppFile/1220/1992; https://medvis.vidar.ru/jour/article/downloadSuppFile/1220/1993; https://medvis.vidar.ru/jour/article/downloadSuppFile/1220/1994; https://medvis.vidar.ru/jour/article/downloadSuppFile/1220/1995; Axel L. Cerebral blood flow determination by rapid-sequence computed tomography: theoretical analysis. Radiology. 1980; 137 (3): 679–686. http://doi.org/10.1148/radiology.137.3.7003648; Koh T., Tan C., Cheong L. et al. Cerebral perfusion mapping using a robust and efficient method for deconvolution analysis of dynamic contrast-enhanced images. Neuroimage. 2006; 32 (2): 643–653. http://doi.org/10.1016/j.neuroimage.2006.03.042; Schaefer P., Roccatagliata L., Ledezma C. et al. First-pass quantitative CT perfusion identifies thresholds for salvageable penumbra in acute stroke patients treated with intra-arterial therapy. Am. J. Neuroradiol. 2006; 27 (1): 20–25. PMID: 16418350; d'Esterre C., Roversi G., Padroni M. et al. CT perfusion cerebral blood volume does not always predict infarct core in acute ischemic stroke. Neurol. Sci. 2015; 36 (10): 1777–1783. http://doi.org/10.1007/s10072-015-2244-8; Murphy B., Fox A., Lee D. et al. Identification of penumbra and infarct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood volume measurements. Stroke. 2006; 37 (7): 1771–1777. http://doi.org/10.1161/01.STR.0000227243.96808.53; Alves J., Carneiro Â., Xavier J. Reliability of CT perfusion in the evaluation of the ischaemic penumbra. Neuroradiol. J. 2014; 27 (1): 91–95. http://doi.org/10.15274/NRJ-2014-10010; Konig M., Banach-Planchamp R., Kraus M. et al. CT perfusion imaging in acute ischemic cerebral infarct: comparison of cerebral perfusion maps and conventional CT findings. Rofo. 2000; 172 (3): 219–226. German. http://doi.org/10.1055/s-2000-120. PMID: 10778451; Koenig M., Kraus M., Theek C. et al. Quantitative assessment of the ischemic brain by means of perfusion-related parameters derived from perfusion CT. Stroke. 2001; 32 (2): 431–437. http://doi.org/10.1161/01.str.32.2.431; Miles K., Hayball., Dixon A. Colour perfusion imaging: a new application of computed tomography. Lancet. 1991; 337 (8742): 643–645. http://doi.org/10.1016/0140-6736(91)92455-b; Kambadakone A., Sahani D. Body perfusion CT: technique, clinical applications, and advances. Radiol. Clin. N. Am. 2009; 47 (1): 161–178. http://doi.org/10.1016/j.rcl.2008.11.003.; Petralia G., Bonello L., Viotti S. et al. CT perfusion in oncology: how to do it. Cancer Imaging. 2010; 10 (1): 8–19. http://doi.org/10.1102/1470-7330.2010.0001; Garcia-Figueiras R., Goh V., Padhani A. et al. CT perfusion in oncologic imaging: a useful tool? Am. J. Roentgenol. 2013; 200 (1): 8–19. http://doi.org/10.2214/AJR.11.8476; Sitartchouk I., Roberts H., Pereira A. et al. Computed tomography perfusion using first pass methods for lung nodule characterization. Invest. Radiol. 2008; 43: 349–358. http://doi.org/10.1097/RLI.0b013e3181690148; Sahani D., Holalkere N., Mueller P. et al. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue-initial experience. Radiology. 2007; 243: 736–743. http://doi.org/10.1148/radiol.2433052020; Rumboldt Z., Al-Okaili R., Deveikis J. Perfusion CT for head and neck tumors: pilot study. Am. J. Neuroradiol. 2005; 26: 1178–1785. PMID: 15891181; Li Y., Yang Z., Chen T., Chen H. et al. Peripheral lung carcinoma: correlation of angiogenesis and first-pass perfusion parameters of 64-detector row CT. Lung Cancer. 2008; 61: 44–53. http://doi.org/10.1016/j.lungcan.2007.10.021.; d’Assignies G., Couvelard A., Bahrami S. et al. Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology. 2008; 250: 407_16. http://doi.org/10.1148/radiol.2501080291.; Feng S., Sun C., Li Z. et al. Evaluation of microvessel density and vascular endothelial growth factor in colorectal carcinoma with 64-multidetector-row CT perfusion imaging. Zhonghua Wei Chang Wai Ke Za Zhi. 2008; 11: 537–541. PMID: 19031129; Grenier N., Cornelis F., Le Bras Y. et al. Perfusion imaging in renal diseases. Diagn. Interv. Imaging. 2013; 94 (12): 1313–1322. http://doi.org/10.1016/j.diii.2013.08.018; Das C., Thingujam U., Panda A. et al. Perfusion computed tomography in renal cell carcinoma. Wld J. Radiol. 2015; 7 (7): 170–179. http://doi.org/10.4329/wjr.v7.i7.170; Prezzi D., Khan A., Goh V. Perfusion CT imaging of treatment response in oncology. Eur. J. Radiol. 2015; 84 (12): 2380–2385. http://doi.org/10.1016/j.ejrad.2015.03.022; El-Diasty M., Gaballa G., Gad H. et al. Evaluation of CT perfusion parameters for assessment of split renal function in healthy donors. Egypt. J. Radiol. Nuclear Med. 2016; 47 (4): 1681–1688. http://doi.org/10.1016/j.ejrnm.2016.07.017; Cai X.-R., Zhou Q.C., Yu J. et al. Assessment of renal function in patients with unilateral ureteral obstruction using whole-organ perfusion imaging with 320-detector row computed tomography. PLoS One. 2015; 10 (4): e0122454. http://doi.org/10.1371/journal.pone.0122454; Yilmaz O., Ovali G., Genc A. et al. Perfusion computed tomography could be a new tool for single-session imaging of ureteric obstructive pathology: an experimental study in rats. J. Pediatr. Surg. 2009; 44 (10): 1977–1983. http://doi.org/10.1016/j.jpedsurg.2009.01.072; Grenier N., Merville P., Combe C. Radiologic imaging of the renal parenchyma structure and function. Nat. Rev. Nephrol. 2016; 12 (6): 348–359. http://doi.org/10.1038/nrneph.2016.44; Helck A., Wessely M., Notohamiprodjo M. et al. CT perfusion technique for assessment of early kidney allograft dysfunction: preliminary results. Eur. Radiol. 2013; 23 (9): 2475–2481. http://doi.org/10.1007/s00330-013-2862-6; Deniffel D., Boutelir T., Labani A. et al. Computed tomography perfusion measurements in renal lesions obtained by bayesian estimation, advanced singular-value decomposition deconvolution, maximum slope and Patlak models. Invest. Radiol. 2018; 53 (8): 477–485. http://doi.org/10.1097/RLI.0000000000000477; Chen Y., Zhang J., Dai J. et al. Angiogenesis of renal cell carcinoma: perfusion CT findings. Abdom. Imaging. 2010; 35 (5): 622–628. http://doi.org/10.1007/s00261-009-9565-0; Chen C., Liu Q., Hao Q. et al. Study of 320-slice dynamic volume CT perfusion in different pathologic types of kidney tumor: preliminary results. PLoS One. 2014; 9 (1): e85522. http://doi.org/10.1371/journal.pone.0085522; Chen C., Kang Q., Xu B. et al. Fat poor angiomyolipoma differentiation from renal cell carcinoma at 320-slice dynamic volume CT perfusion. Abdom. Radiol. (NY). 2018; 43 (5): 1223–1230. http://doi.org/10.1007/s00261-017-1286-1; Mazzei F., Mazzei M., Cioffi Squitieri N. et al. CT perfusion in the characterisation of renal lesions: an added value to multiphasic CT. Biomed. Res. Int. 2014; 2014: 135013. http://doi.org/10.1155/2014/135013; Reiner C., Goetti R., Eberli D. et al. CT perfusion of renal cell carcinoma: impact of volume coverage on quantitative analysis. Invest. Radiol. 2012; 47 (1): 33–40. http://doi.org/10.1097/RLI.0b013e31822598c3; Reiner C., Roessle M., Thiesler T. et al. Computed tomography perfusion imaging of renal cell carcinoma: systematic comparison with histopathological angiogenic and prognostic markers. Invest. Radiol. 2013; 48 (4): 183–191. http://doi.org/10.1097/RLI.0b013e31827c63a3; Rosenbaum C., Wach S., Kunath F. et al. Dynamic tissue perfusion measurement: a new tool for characterizing renal perfusion in renal cell carcinoma patients. Urol. Int. 2013; 90 (1): 87–94. http://doi.org/10.1159/000341262; Рубцова Н.А., Гольбиц А.Б., Крянева Е.В. и др. Роль КТ-перфузии в диагностике солидных опухолей почек. Лучевая диагностика и терапия. 2021; 2 (12): 70–78. http://doi.org/10.22328/2079-5343-2021-12-2-70-78; Chen C., Kang Q., Wei Q. et al. Correlation between CT perfusion parameters and Fuhrman grade in pTlb renal cell carcinoma. Abdom. Radiol (NY). 2017; 42 (5): 1464–1471. http://doi.org/10.1007/s00261-016-1009-z.; Chen C., Kang Q., Xu B. et al. Differentiation of low- and high-grade clear cell renal cell carcinoma: Tumor size versus CT perfusion parameters. Clin. Imaging. 2017; 46: 14–19. http://doi.org/10.1016/j.clinimag.2017.06.010; Shu J., Tang Y., Cui J. et al. Clear cell renal cell carcinoma: CT-based radiomics features for the prediction of Fuhrman grade. Eur. J. Radiol. 2018; 109: 8–12. http://doi.org/10.1016/j.ejrad.2018.10.005; Drljevic-Nielsen A., Rasmussen F., Mains J. et al. Baseline blood volume identified by dynamic contrast-enhanced computed tomography as a new independent prognostic factor in metastatic renal cell carcinoma. Transl. Oncol. 2020; 13 (10): 100829. http://doi.org/10.1016/j.tranon.2020.100829; Mains J., Donskov F, Pedersen E. et al. Dynamic Contrast-Enhanced Computed Tomography-Derived Blood Volume and Blood Flow Correlate With Patient Outcome in Metastatic Renal Cell Carcinoma. Invest. Radiol. 2017; 52 (2): 103–110. http://doi.org/10.1097/RLI.0000000000000315; Mains J., Donskov F., Pedersen E. et al. Use of patient outcome endpoints to identify the best functional CT imaging parameters in metastatic renal cell carcinoma patients. Br. J. Radiol. 2018; 91 (1082): 20160795. http://doi.org/10.1259/bjr.20160795; Fan A., Sundaram V., Kino A. et al. Early Changes in CT Perfusion Parameters: Primary Renal Carcinoma Versus Metastases After Treatment with Targeted Therapy. Cancers (Basel). 2019; 11 (5): 608. http://doi.org/10.3390/cancers11050608; Vehabovic-Delic A., Balic M., Rossmann C. et al. Volume Computed Tomography Perfusion Imaging: Evaluation of the Significance in Oncologic Follow-up of Metastasizing Renal Cell Carcinoma in the Early Period of Targeted Therapy – Preliminary Results. J. Comput. Assist. Tomogr. 2019; 43 (3): 493–498. http://doi.org/10.1097/RCT.0000000000000848; Fournier L., Oudard S., Thiam R. et al. Metastatic renal carcinoma: evaluation of antiangiogenic therapy with dynamic contrast-enhanced CT. Radiology. 2010; 256 (2): 511–518. http://doi.org/10.1148/radiol.10091362; Hudson J., Bailey C., Atri M. et al. The prognostic and predictive value of vascular response parameters measured by dynamic contrast-enhanced-CT, -MRI and -US in patients with metastatic renal cell carcinoma receiving sunitinib. Eur. Radiol. 2018; 28 (6): 2281–2290. http://doi.org/10.1007/s00330-017-5220-2; Nielsen T., Ostraat O., Graumann O. et al. Computed Tomography Perfusion, Magnetic Resonance Imaging, and Histopathological Findings After Laparoscopic Renal Cryoablation: An In Vivo Pig Model. Technol. Cancer Res. Treat. 2017; 16 (4): 406–413. http://doi.org/10.1177/1533034616657251; Squillaci E., Manenti G., Cicciò C. et al. Perfusion-CT monitoring of cryo-ablated renal cells tumors. J. Exp. Clin. Cancer Res. 2009; 28 (1): 138. http://doi.org/10.1186/1756-9966-28-138; Александрова К.А., Серова Н.С., Руденко В.И. и др. Возможности КТ-перфузии в оценке почечного кровотока у пациентов с мочекаменной болезнью. Российский электронный журнал лучевой диагностики. 2019; 9 (1): 108–117. http://doi.org/10.21569/22227415201991108117; Александрова К.А., Серова Н.С., Руденко В.И. и др. Клиническое значение КТ-перфузии у пациентов с камнями мочеточника. Урология. 2019; 5: 38–43. http://doi.org/10.18565/urology.2019.5.38-43; Александрова К.А., Серова Н.С., Руденко В.И. и др. Оценка перфузии почек у больных мочекаменной болезнью с помощью методов лучевой диагностики. Российский электронный журнал лучевой диагностики. 2018; 8 (4) 208–219. http://doi.org/10.21569/2222-7415-2018-8-4-208-219; Zhang Z., Cen C., Qian K. et al. Assessment of the embolization effect of temperature-sensitive p(N-isopropylacrylamide-co-butyl methylacrylate) nanogels in the rabbit renal artery by CT perfusion and confirmed by macroscopic examination. Sci. Rep. 2021; 11 (1): 4826. http://doi.org/10.1038/s41598-021-84372-w; Zhong J., Yuan J., Chong V. et al. The clinical application of one-stop examination with 640-slice volume CT for Nutcracker syndrome. PLoS One. 2013; 8 (9): e74365. http://doi.org/10.1371/journal.pone.0074365; Liu D., Liu J., Wen Z. et al. 320-row CT renal perfusion imaging in patients with aortic dissection: A preliminary study. PLoS One. 2017; 12 (2): e0171235. http://doi.org/10.1371/journal.pone.0171235; Al-Said J., Kamel O. Changes in renal cortical and medullary perfusion in a patient with renal vein thrombosis. Saudi J. Kidney Dis. Transpl. 2010; 21 (1): 123–127. PMID: 20061706.; Braunagel M., Helck A., Wagner A. et al. Dynamic Contrast-Enhanced Computed Tomography: A New Diagnostic Tool to Assess Renal Perfusion After Ischemia-Reperfusion Injury in Mice: Correlation of Perfusion Deficit to Histopathologic Damage. Invest. Radiol. 2016; 51 (5): 316–322. http://doi.org/10.1097/RLI.0000000000000245; Miles K., Griffiths M. Perfusion CT: a worthwhile enhancement? Br. J. Radiol. 2003; 76 (904): 220–231. http://doi.org/10.1259/bjr/13564625; Miles K. Perfusion CT for the assessment of tumour vascularity: which protocol? Br. J. Radiol. 2003; 76 Spec No 1: S36–42. http://doi.org/10.1259/bjr/18486642; Гольбиц А.Б., Рубцова Н.А., Крянева Е.В. и др. КТперфузия почек в онкологии: учебно-методическое пособие. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ “НМИЦ радиологии” Минздрава России. 2020. 28 с.; Jeong S., Park S., Chang I., Shin J. et al. Estimation of renal function using kidney dynamic contrast material-enhanced CT perfusion: accuracy and feasibility. Abdom. Radiol. (NY). 2021; 46 (5): 2045–2051. http://doi.org/10.1007/s00261-020-02826-7.; https://medvis.vidar.ru/jour/article/view/1220

الاتاحة: https://medvis.vidar.ru/jour/article/view/1220
https://doi.org/10.24835/1607-0763-1220

المؤلفون: Ionescu, N., Mocanu, M., Bogdan, A., Stănescu, D., Bunea, B., Dobrescu, A.

المصدر: Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale 73-S (2) 32-37

مصطلحات موضوعية: tumoră renală, chist renal, clasificare Bosniak, tumora Wilms, renal tumour, Renal cyst, Bosniak classification, Wilms Tumour, опухоль почки, киста почки, боснийская классификация, опухоль Вильмса

وصف الملف: application/pdf

Relation: https://ibn.idsi.md/vizualizare_articol/173317; urn:issn:18570011

الاتاحة: https://ibn.idsi.md/vizualizare_articol/173317
https://doi.org/10.52692/1857-0011.2022.2-73.04

المؤلفون: I. O. Dementyev, V. S. Chaykov, A. V. Troyanov, D. A. Parkov, E. O. Shchukina, O. A. Anurova, A. A. Fedenko, A. D. Kaprin, S. A. Ivanov, И. О. Дементьев, В. С. Чайков, А. В. Троянов, Д. А. Парков, Е. О. Щукина, О. А. Анурова, А. А. Феденко, А. Д. Каприн, С. А. Иванов

المساهمون: Медицинский радиологический научный центр им А.Ф. Цыба – филиал ФГБУ «Национальный медицинский исследовательский центр радиологии» Минздрава России

المصدر: Cancer Urology; Том 18, № 1 (2022); 143-150 ; Онкоурология; Том 18, № 1 (2022); 143-150 ; 1996-1812 ; 1726-9776

مصطلحات موضوعية: редкая опухоль почки, diagnosis of leiomyosarcoma, renal sarcoma, rare kidney (renal) tumor, диагностика лейомиосаркомы, саркомы почек

وصف الملف: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1522/1347; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1522/1073; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1522/1074; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1522/1082; Hui J.Y.C. Epidemiology and etiology of sarcomas. Surg Clin North Am 2016;96(5):901–14. DOI:10.1016/j.suc.2016.05.005.; Gatta G., van der Zwan J.M., Casali P.G. et al. Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer Oxf Engl 1990;2011(47):2493–511. DOI:10.1016/j.ejca.2011.08.008.; Vogelzang N.J., Fremgen A.M., Guinan P.D. et al. Primary renal sarcoma in adults. A natural history and management study by American Cancer Society, Illinois Division. Cancer 1993;71(3):804–10. DOI:10.1002/10970142(19930201)71:33.0.co;2-a.; WHO classification of tumours of the urinary system and male genital organs. Eds.: H. Moch, P.A. Humphrey, T.M. Ulbright, V.E. Reuter. 4th edn.; Lopez-Beltra A., Menendez C.L., Montironi R., Cheng L. Rare tumors and, tumor-like conditions in urological pathology. DOI:10.1007/978-3-319-10253-5.; Павлов А.Ю., Гармаш С.В., Исаев Т.К. и др. Современные представления о лейомиосаркомах вен забрюшинного пространства. Обзор клинических случаев. Онкоурология 2016;12(2):92–6. DOI:10.17650/1726-9776-2016-12-2-92-96.; Choudhury M., Singh S.K., Pujani M. et al. A case of leiomyosarcoma of kidney clinically and radiologically misdiagnosed as renal cell carcinoma. Indian J Cancer 2009;46(3):241–3. DOI:10.4103/0019-509X.52962.; Novak M., Perhavec A., Maturen K.E. et al. Leiomyosarcoma of the renal vein: analysis of outcome and prognostic factors in the world case series of 67 patients. Radiol Oncol 2016;51(1): 56–64. DOI:10.1515/raon-2016-0051.; Brown C.J., Greally J.M. Review A stain upon the silence: genes escaping X inactivation. Trends Genet 2003;19(8):432–8. DOI:10.1016/S0168-9525(03)00177-X.; Valery J.R., Tan W., Cortese C. Renal leiomyosarcoma: a diagnostic challenge. Case Rep Oncol Med 2013;2013:459282. DOI:10.1155/2013/459282.; Aguilar I.C., Benavente V.A., Pow-Sang M.R. et al. Leiomyosarcoma of the renal vein: case report and review of the literature Urol Oncol 2005;23(1):22–6. DOI:10.1016/j.urolonc.2004.06.004.; Iwata J., Fletcher C.D. Immunohistochemical detection of cytokeratin and epithelial membrane antigen in leiomyosarcoma: a systematic study of 100 cases. Pathol Int 2000;50(1):7–14. DOI:10.1046/j.1440-1827.2000.01001.x.; Deyrup A.T., Montgomery E., Fisher C. Leiomyosarcoma of the kidney: a clinicopathologic study. Am J Surg Pathol 2004;28(2): 178–82. DOI:10.1097/00000478-200402000-00004.; Demir A., Yazici C.M., Eren F., Türkeri L. Case report: good prognosis in leiomyosarcoma of the kidney. Int Urol Nephrol 2007;39(1):7–10. DOI:10.1007/s11255-005-4025-4.; Кригер А.Г., Берелавичус С.В., Сон А.И. и др. Хирургическое лечение неорганных забрюшинных опухолей. Хирургия. Журнал им. Н.И. Пирогова 2017;(1):15–26. DOI:10.17116/hirurgia2017115-26.; Raut C.P., Pisters P.W. Review retroperitoneal sarcomas: combined-modality treatment approaches. J Surg Oncol 2006;94(1):81–7. DOI:10.1002/jso.20543.; Young S., Amirali S., Christopher S. et al. Renal leiomyosarcoma: case report and review of the literature. World J Nephrol Urol 2015;4(2):213–7. DOI:10.14740/wjnu214w.; Zafar R., Manthri S., Shurbaji M.S. Renal leiomyosarcoma. StatPearls Publishing, 2021.; Mahmood S.T., Agresta S., Vigil C.E. et al. Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: leiomyosarcoma, liposarcoma and malignant fibrous histiocytoma. Int J Cancer 2011;15;129(8):1963–9. DOI:10.1002/ijc.25843.; Ozturk H. High-grade primary renal leiomyosarcoma. Int Braz J Urol 2015;41(2):304–11. DOI:10.1590/S1677-5538.IBJU.2015.02.17.; https://oncourology.abvpress.ru/oncur/article/view/1522

الاتاحة: https://oncourology.abvpress.ru/oncur/article/view/1522
https://doi.org/10.17650/1726-9776-2022-18-1-143-150

المؤلفون: D. Gorduladze N., E. Sirota S., L. Rapoport M., V. Gridin N., D. Tsarichenko G., I. Kuznetsov A., P. Bochkaryov V., Yu. Alyaev G., Д. Гордуладзе Н., Е. Сирота С., Л. Рапопорт М., В. Гридин Н., Д. Цариченко Г., И. Кузнецов А., П. Бочкарев В., Ю. Аляев Г.

المساهمون: The work was performed within the framework of the theme No. 0071-2019-0001., Работа выполнена в рамках темы № 0071-2019-0001.

المصدر: Cancer Urology; Том 17, № 4 (2021); 129-135 ; Онкоурология; Том 17, № 4 (2021); 129-135 ; 1996-1812 ; 1726-9776

مصطلحات موضوعية: texture analysis, machine learning, radiomics, 5P medicine, multispiral computed tomography, magnetic resonance imaging, renal tumor, текстурный анализ, машинное обучение, радиомика, 5П-медицина, мультиспиральная компьютерная томография, магнитно-резонансная томография, опухоль почки

وصف الملف: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1436/1335; Wilhelm Konrad Roentgen-The Centennial of His Birth-Semicentennial of the X-Rays. JAMA 2020;323(15):1512. DOI:10.1001/jama.2019.13400.; Hounsfield G.N. Computerized transverse axial scanning (tomography): Part I. Description of system 1975. Br J Radiol 1973;68(815):H166-72.; Pincock S. US and UK researchers share Nobel prize. Paul C. Lauterbur and Peter Mansfield share award for seminal work on MRI. Lancet 2003;362(9391):1203. DOI:10.1016/s0140-6736(03)14557-6.; Davnall F., Yip C.S.P., Ljungqvist G. et al. Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging 2012;3(6):573-89. DOI:10.1007/s13244-012-0196-6.; Haralick R.M., Shanmugam K., Dinstein I. Textural features for image classification. IEEE Trans Syst Man Cybern 1973;SMC-3(6):610-21. DOI:10.1109/TSMC.1973.4309314.; Aerts H.J.W.L. The potential of radiomic-based phenotyping in precisionmedicine a review. JAMA Oncol 2016;2(12):1636-42. DOI:10.1001/jamaoncol.2016.2631.; Lubner M.G., Smith A.D., Sandrasegaran K. et al. CT Texture Analysis: Definitions, Applications, Biologic Correlates, and Challenges. Radiographics 2017;37(5):1483-503. DOI:10.1148/rg.2017170056.; Blobel B., Ruotsalainen P., Brochhausen M. et al. Autonomous systems and artificial intelligence in healthcare transformation to 5p medicine - ethical challenges. Stud Health Technol Inform 2020;270:1089-93. DOI:10.3233/SHTI200330.; DeCastro G.J., McKiernan J.M. Epidemiology, clinical staging, and presentation of renal cell carcinoma. Urol Clin North Am 2008;35(4):581-92. DOI:10.1016/j.ucl.2008.07.005.; Frank I., Blute M.L., Cheville J.C. et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 2003;170(6 Pt 1):2217-20. DOI:10.1097/01.ju.0000095475.12515.5e.; Zhou L., Zhang Z., Chen Y.C. et al. A deep learning-based radiomics model for differentiating benign and malignant renal tumors. Transl Oncol 2019;12(2):292-300. DOI:10.1016/j.tranon.2018.10.012.; Said D., Hectors S.J., Wilck E. et al. Characterization of solid renal neoplasms using MRI-based quantitative radiomics features. Abdom Radiol 2020;45(9):2840-50. DOI:10.1007/s00261-020-02540-4.; Uhlig J., Biggemann L., Nietert M.M. et al. Discriminating malignant and benign clinical T1 renal masses on computed tomography: a pragmatic radiomics and machine learning approach. Medicine 2020;99(16):e19725. DOI:10.1097/MD.0000000000019725.; Yap F.Y., Varghese B.A., Cen S.Y. et al. Shape and texture-based radiomics signature on CT effectively discriminates benign from malignant renal masses. Eur Radiol 2021;31(2):1011-21. DOI:10.1007/s00330-020-07158-0.; Deng Y., Soule E., Samuel A. et al. CT texture analysis in the differentiation of major renal cell carcinoma subtypes and correlation with Fuhrman grade. Eur Radiol 2019;29(12):6922-9. DOI:10.1007/s00330-019-06260-2.; Erdim C., Yardimci A.H., Bektas C.T. et al. Prediction of benign and malignant solid renal masses: machine learning-based CT texture analysis. Acad Radiol 2020;27(10):1422-9. DOI:10.1016/j.acra.2019.12.015.; Xi I.L., Zhao Y., Wang R. et al. Deep learning to distinguish benign from malignant renal lesions based on routine MR imaging. Clin Cancer Res 2020;26(8):1944-52. DOI:10.1158/1078-0432.CCR-19-0374.; Znaor A., Lortet-Tieulent J., Laversanne M. et al. International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol 2015;67(3):519-30. DOI:10.1016/j.eururo.2014.10.002.; Cheville J.C., Lohse C.M., Zincke H. et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003;27(5):612-24. DOI:10.1097/00000478-200305000-00005.; Yu H.S., Scalera J., Khalid M. et al. Texture analysis as a radiomic marker for differentiating renal tumors. Abdom Radiol 2017;42(10):2470-8. DOI:10.1007/s00261-017-1144-1.; Zhang G.M.Y., Shi B., Xue H.D. et al. Can quantitative CT texture analysis be used to differentiate subtypes of renal cell carcinoma? Clin Radiol 2019;74(4):287-94. DOI:10.1016/j.crad.2018.11.009.; Duan C., Li N., Niu L. et al. CT texture analysis for the differentiation of papillary renal cell carcinoma subtypes. Abdom Radiol 2020;45(11):3860-8. DOI:10.1007/s00261-020-02588-2.; Wang W., Cao K.M., Jin S.M. et al. Differentiation of renal cell carcinoma subtypes through MRI-based radiomics analysis. Eur Radiol 2020;30(10):5738—47. DOI:10.1007/s00330-020-06896-5.; Fuhrman S., Lasky L.C., Limas C. Prognostic significance of morphologic parametrs in renal cell carcinoma. Am J Surg Pathol 1982;6(7):655-63. DOI:10.1097/00000478-198210000-00007.; Moch H., Cubilla A.L., Humphrey P.A. et al. The 2016 WHO classification of tumours of the urinary system and male genital organs — part A: renal, penile, and testicular tumours. Eur Urol 2016;70(1):93-105. DOI:10.1016/j.eururo.2016.02.029.; Tsui K.H., Shvarts O., Smith R.B. et al. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol 2000;163(4):1090-5. DOI:10.1016/S0022-5347(05)67699-9.; Feng Z., Shen Q., Li Y., Hu Z. CT texture analysis: a potential tool for predicting the Fuhrman grade of clear-cell renal carcinoma. Cancer Imaging 2019;19(1):6. DOI:10.1186/s40644-019-0195-7.; Goyal A., Razik A., Kandasamy D. et al. Role of MR texture analysis in histological subtyping and grading of renal cell carcinoma: a preliminary study. Abdom Radiol 2019;44(10):3336-49. DOI:10.1007/s00261-019-02122-z.; Boos J., Revah G., Brook O.R. et al. CT intensity distribution curve (Histogram) analysis of patients undergoing antiangiogenic therapy for metastatic renal cell carcinoma. Am J Roentgenol 2017;209(2):W85-92. DOI:10.2214/AJR.16.17651.; Bharwani N., Miquel M.E., Powles T. et al. Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinoma. Br J Cancer 2014;110(3):616-24. DOI:10.1038/bjc.2013.790.; Ueno D., Yao M., Tateishi U. et al. Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course. BMC Cancer 2012;12:162. DOI:10.1186/1471-2407-12-162.; Antunes J., Viswanath S., Rusu M. et al. Radiomics analysis on FLT-PET/MRI for characterization of early treatment response in renal cell carcinoma: a proof-of-concept study. Transl Oncol 2016;9(2):155-62. DOI:10.1016/j.tranon.2016.01.008.; Goh V., Ganeshan B., Nathan P. et al. Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker. Radiology 2011;261(1):165-71. DOI:10.1148/radiol.11110264.; https://oncourology.abvpress.ru/oncur/article/view/1436

الاتاحة: https://oncourology.abvpress.ru/oncur/article/view/1436
https://doi.org/10.17650/1726-9776-2021-17-4-129-135

المؤلفون: S. V. Kotov, A. A. Nemenov, A. G. Yusufov, R. I. Guspanov, S. A. Pulbere, A. O. Prostomolotov, С. В. Котов, А. А. Неменов, А. Г. Юсуфов, Р. И. Гуспанов, С. А. Пульбере, А. О. Простомолотов

المصدر: Cancer Urology; Том 17, № 4 (2021); 38-46 ; Онкоурология; Том 17, № 4 (2021); 38-46 ; 1996-1812 ; 1726-9776

مصطلحات موضوعية: органосохраняющее лечение, kidney tumor, laparoscopic partial nephrectomy, nephron-sparing surgery, опухоль почки, лапароскопическая резекция почки

وصف الملف: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1470/1326; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1470/1002; Состояние онкологической помощи населению России в 2019 году. Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2020. 239 с.; Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer. Available at: https://gco.iarc.fr/today. (accessed March 2, 2020).; Campbell S., Uzzo R.G., Allaf M.E. et al. Renal mass and localized renal cancer: AUA guideline. J Urol 2017;198(3):520-9. DOI:10.1016/j.juro.2017.04.100.; Lee H., Oh J.J., Byun S.S. et al. Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (≥4 cm)? A propensity score-matched study. Urol Oncol 2017;35(6):379-85. DOI:10.1016/j.urolonc.2017.02.002.; SEER Explorer. Available at: https://seer.cancer.gov/explorer/index.html. (accessed March 2, 2020).; Chevrier S., Levine J.H., Zanotelli V.R.T. et al. An immune atlas of clear cell renal cell carcinoma. Cell 2017;169(4):736-49.e718. DOI:10.1016/j.cell.2017.04.016.; Kane C.J., Mallin K., Ritchey J. et al. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer 2008;113(1):78-83. DOI:10.1002/cncr.23518.; Campbell S.C., Novick A.C., Belldegrun A. et al. Guideline for management of the clinical T1 renal mass. J Urol 2009;182(4):1271-9. DOI:10.1016/j.juro.2009.07.004.; Liss M.A., Wang S., Palazzi K. et al. Evaluation of national trends in the utilization of partial nephrectomy in relation to the publication of the American Urologic Association guidelines for the management of clinical T1 renal masses. BMC Urol 2014;14:101. DOI:10.1186/1471-2490-14-101.; Krane L.S., Hemal A.K. Robotic and laparoscopic partial nephrectomy for T1b tumors. Curr Opin Urol 2013;23(5):418-22. DOI:10.1097/MOU.0b013e32836320d2.; Al-Qudah S., Rodriguez A.R., Sexton W.J. Laparoscopic management of kidney cancer: updated review. Cancer Control 2007;14(3):218-30. DOI:10.1177/107327480701400304.; Van Poppel H., Da Pozzo L., Albrecht W. et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephronsparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59(4):543-52. DOI:10.1016/j.eururo.2010.12.013.; Аляев Ю.Г., Сирота Е.С., Рапопорт Л.М. и др. Сравнение значимости шкал нефрометрической оценки RENAL, PADUA, С-index для прогноза сложности лапароскопической резекции почки. Онкоурология 2018;14(1):36-46. DOI:10.17650/1726-97762018-14-1-36-46.; Colombo J.R.Jr, Haber G.P., Gill I.S. Laparoscopic partial nephrectomy in patients with compromised renal function. Urology 2008;71(6):1043-8. DOI:10.1016/j.urology.2007.11.022.; Chan A.A., Wood C.G., Caicedo J. et al. Predictors of unilateral renal function after open and laparoscopic partial nephrectomy. Urology 2010;75(2):295-302. DOI:10.1016/j.urology.2009.09.027.; La Rochelle J., Shuch B., Riggs S. et al. Functional and oncological outcomes of partial nephrectomy of solitary kidneys. J Urol 2009;181(5):2037-42. DOI:10.1016/j.juro.2009.01.024; Berczi C., Thomas B., Bacso Z., Flasko T. Long-term oncological and functional outcomes of partial nephrectomy in solitary kidneys. Clin Genitourin Cancer 2016;14(3):e275-81. DOI:10.1016/j.clgc.2015.11.014.; Alyami F., Rendon R. Laparoscopic partial nephrectomy for >4 cm renal masses. Canad Urol Assoc J 2013;7(5-6):281. DOI:10.5489/cuaj.1003.; Сирота Е.С., Рапопорт Л.М., Гридин В.Н. и др. Анализ кривой обучения хирургов в зависимости от сложности нефрометрической оценки при выполнении лапароскопической резекции почки у пациентов с локализованными образованиями паренхимы почки. Урология 2020;6: 11-8. DOI:10.18565/urology.2020.6.11-18.; Bahler C.D., Sundaram C.P. Effect of renal reconstruction on renal function after partial nephrectomy. J Endourol 2016;30(Suppl 1):S37-41. DOI:10.1089/end.2016.0055.; Tubre R.W., Parker W.P., Dum T. et al. Findings and impact of early imaging after partial nephrectomy. J Endourol 2017;31(3):320-5. DOI:10.1089/end.2016.0568.; Kim T.S., Park J.G., Kang H. et al. Computed tomography imaging features and changes in hemostatic agents after laparoscopic partial nephrectomy. J Endourology 2016;30(9):950-7. DOI:10.1089/end.2016.0263.; Novick A.C., Streem S., Montie J.E. et al. Conservative surgery for renal cell carcinoma: a single-center experience with 100 patients. J Urol 1989;141(4):835-9. DOI:10.1016/s0022-5347(17)41026-3.; Lapini A., Serni S., Minervini А. et al. Progression and long-term survival after simple enucleation for the elective treat- mentof renal cell carcinoma: experience in 107 patients. J Urol 2005;174(1):57-60. DOI:10.1097/01.ju.0000162019.45820.53.; Serni S., Vittori G., Frizzi J. et al. Simple enucleation for the treatment of highly complex renal tumors: perioperative, functional and oncological results. Eur J Surg Oncol 2015;41(7):934-40. DOI:10.1016/j.ejso.2015.02.019.; Wood E.L., Adibi M., Qiao W. et al. Local tumor bed recurrence following partial nephrectomy in patients with small renal masses. J Urol 2018;199(2):393-400. DOI:10.1016/j.juro.2017.09.072; Аляев Ю.Г., Рапопорт Л.М., Сирота Е.С. и др. Местный рецидив после выполнения лапароскопических резекций при раке паренхимы почки. Андрология и генитальная хирургия 2017;18(4):61-8. DOI:10.17650/2070-9781-2017-18-4-61-68.; Волкова М.И., Ридин В.А., Черняев В.А. и др. Нужна ли технически сложная резекция больным опухолями почечной паренхимы с нормальной контралатеральной почкой? Онкоурология 2019;15(4):39-49. DOI:10.17650/1726-97762019-15-4-39-49.; https://oncourology.abvpress.ru/oncur/article/view/1470

الاتاحة: https://oncourology.abvpress.ru/oncur/article/view/1470
https://doi.org/10.17650/1726-9776-2021-17-4-38-46

المؤلفون: V. Latypov R., O. Popov S., S. Novikov I., V. Latypova N., D. Ahmedov B., В. Латыпов Р., О. Попов С., С. Новиков И., В. Латыпова Н., Д. Ахмедов Б.

المصدر: Cancer Urology; Том 17, № 3 (2021); 140-144 ; Онкоурология; Том 17, № 3 (2021); 140-144 ; 1996-1812 ; 1726-9776

مصطلحات موضوعية: giant tumor, renal cancer, radical nephrectomy of a large renal tumor, extraorgan tumor of the retroperitoneal space, differential diagnosis, гигантская опухоль почки, почечно-клеточный рак, радикальная нефрэктомия большой почечной опухоли, внеорганная опухоль забрюшинного пространства, дифференциальная диагностика

وصف الملف: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1429/1307; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1429/969; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1429/970; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1429/971; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1429/972; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1429/973; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1429/974; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1429/975; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1429/976; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1429/977; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1429/978; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1429/979; Рева И.А., Бормотин А.В., Дьяков В.В. и др. Опухоль почки крупных размеров, имитирующая внеорганную опухоль забрюшинного пространства: клинический случай. Онкоурология 2015;(1):64—7. DOI:10.17650/1726-9776-2015-1-64-67.; Oviedo R.J., Robertson J.C., Whithaus K. Surgical challenges in the treatment of a giant renal cell carcinoma with atypical presentation: a case report. Int J Surg Case Rep 2016;24:63-6. DOI:10.1016/j.ijscr.2016.05.010.; Takagi T., Sugihara T., Yasunaga H. et al. Cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based analysis of perioperative outcomes according to clinical stage. Int J Urol 2014;21(8):770-5. DOI:10.1111/iju.12446.; Wszolek M.F., Wotkowicz C., Libertino J.A. Surgical management of large renal tumors. Nat Clin Pract Urol 2008;5(1):35—46. DOI:10.1038/ncpuro0963.; Turkan S., Kalkan M., Basri §ener H. et al. Giant chromophobe renal cell carcinoma. J Case Rep 2015;5(1):5—7.; Suzuki K., Kubo T., Morita T. A giant chromophobe renal cell carcinoma exceeding 10 kg. Int J Urol 2009;16(12):976. DOI:10.1111/j.1442-2042.2009.02402.x.; Pramod S.V., Safriad F., Hernowo B.S. et al. A case report of one of the largest (9900 cm3) clear cell renal carcinoma removed in Asia. Urol Case Rep 2020;32:101208. DOI:10.1016/j.eucr.2020.101208.; Kogawa T., Kudoh T., Kawaguchi T. et al. Giant renal cell carcinoma: a case report. Nihon Gan Chiryo Gakkai Shi 1989;24(7):1467—71.; https://oncourology.abvpress.ru/oncur/article/view/1429

الاتاحة: https://oncourology.abvpress.ru/oncur/article/view/1429
https://doi.org/10.17650/1726-9776-2021-17-3-140-144

المؤلفون: M. Yusof R., A. Arunasalam P., M. Saiful Azli Z., C. Lee K.S., O. Fahmy, M. Khairul-Asri G.

المصدر: Cancer Urology; Том 17, № 2 (2021); 168-171 ; Онкоурология; Том 17, № 2 (2021); 168-171 ; 1996-1812 ; 1726-9776

مصطلحات موضوعية: renal cell carcinoma, renal tumour, nephrectomy, single port laparoscopic nephrectomy, почечно-клеточный рак, опухоль почки, нефрэктомия, лапароскопическая однопортовая нефрэктомия

وصف الملف: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1444/1282; https://oncourology.abvpress.ru/oncur/article/view/1444/1315; Padala S.A., Barsouk A., Thandra K.C. et al. Epidemiology of renal cell carcinoma. World J Oncol 2020;11(3):79-87. DOI:10.14740/wjon1279.; Singam P., Ho C., Hong G.E. et al. Clinical characteristics of renal cancer in Malaysia: a ten year review. Asian Pac J Cancer Prev 2010;11(2):503-6.; Yusof M.R., Hashim M.N., Mokhter W.M.W. et al. Renal cell carcinoma with IVC thrombosis: modalities and surgical approach - a case report. Surg Chron 2018;23(2):120-3.; Clayman R.V., Kavoussi L.R., Soper N.J. et al. Laparoscopic nephrectomy: initial case report. J Urol 1991;146(2):278-82. DOI:10.1016/s0022-5347(17)37770-4.; Raman J.D., Bensalah K., Bagrodia A. et al. Laboratory and clinical development of single keyhole umbilical nephrectomy. Urology 2007;70(6):1039-42. DOI:10.1016/j.urology.2007.10.001.; Raman J.D., Bagrodia A., Cadeddu J.A. Single-incision, umbilical laparoscopic versus conventional laparoscopic nephrectomy: a comparison of perioperative outcomes and short-term measures of convalescence. Eur Urol 2009;55(5): 1198-204.; Matsumoto K., Miyajima A., Fukumoto K. et al. Factors influencing the operating time for singleport laparoscopic radical nephrectomy: focus on the anatomy and distribution of the renal artery and vein. Jpn J Clin Oncol 2017;47(10):976-80. DOI:10.1093/jjco/hyx105.; Kurien A., Rajapurkar S., Sinha L. et al. First prize: standard laparoscopic donor nephrectomy versus laparoendoscopic single-site donor nephrectomy: a randomized comparative study. J Endourol 2010;25(3):365-70. DOI:10.1089/end.2010.0250.; https://oncourology.abvpress.ru/oncur/article/view/1444

الاتاحة: https://oncourology.abvpress.ru/oncur/article/view/1444
https://doi.org/10.17650/1726-9776-2021-17-2-168-171

المؤلفون: V. Dubrovin N., A. Egoshin V., A. Tabakov V., R. Shakirov R., O. Mihaylovskiy V., В. Дубровин Н., А. Егошин В., А. Табаков В., Р. Шакиров Р., О. Михайловский В.

المصدر: Cancer Urology; Том 16, № 2 (2020); 46-51 ; Онкоурология; Том 16, № 2 (2020); 46-51 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2020-16-2

مصطلحات موضوعية: kidney cancer, laparoscopic partial nephrectomy, thulium fiber laser, опухоль почки, лапароскопическая резекция почки, тулиевый волоконный лазер

وصف الملف: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1019/1168; Van Poppel H., Da Pozzo L., Albrecht W. et al. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephronsparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2007;51(6):1606—15. DOI:10.1016/j.eururo.2006.11.013.; Lee J.H., You C.H., Min G.E. et al. Comparison of the surgical outcome and renal function between radical and nephronsparing surgery for renal cell carcinomas. Korean J Urol 2007;48(7):671-6.; Huang W.C., Elkin E.B., Levey A.S. et al. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors — is there a difference in mortality and cardiovascular outcomes? J Urol 2009;181(1):55-61. DOI:10.1016/j.juro.2008.09.017.; Volpe A., Blute M.L., Ficarra V. et al. Renal ischemia and function after partial nephrectomy: a collaborative review of the literature. Eur Urol 2015;68(1):61—74. DOI:10.1016/j.eururo.2015.01.025.; Bigot P., Verhoest G., Dujardin J. Are warm ischemia and ischemia time still predictive factors of poor renal function after partial nephrectomy in the setting of elective indication? World J Urol 2014;33:11-5. DOI:10.1007/s00345-014-1292-7.; Thompson R.H., Lane B.R., Lohse C.M. et al. Every minute counts when the renal hilum is clamped during partial nephrectomy. Eur Urol 2010;58(3): 340-5. DOI:10.1016/j.eururo.2010.05.047.; Loertzer H., StrauB A., Ringert R.H., Schneider P. Laser-supported partial laparoscopic nephrectomy for renal cell carcinoma without ischaemia time BMC. Urology 2013;13:31. DOI:10.1186/1471-2490-13-31.; Lotan Y., Gettman M.T., Ogan K. et al. Clinical use of the holmium: YAG laser in laparoscopic partial nephrectomy. J Endourol 2002;16(5):289—92. DOI:10.1089/089277902760102767.; Dubrovin V., Egoshin A., Rozhentsov A. et al. Virtual simulation, preoperative planning and intraoperative navigation during laparoscopic partial nephrectomy. Cent European J Urol 2019;3(72):247—51. DOI:10.5173/ceju.2019.1632.; Knight S., Johns E.J. Renal functional responses to ischaemia-reperfusion injury in normotensive and hypertensive rats following non-selective and selective cyclo-oxygenase inhibition with nitric oxide donation. Clin Exp Pharmacol Physiol 2008;35(1):11—6. DOI:10.1111/j.1440-1681.2007.04739.x.; Barlow L., Korets R., Laudano M. et al. Predicting renal functional outcomes after surgery for renal cortical tumours: a multifactorial analysis. BJU Int 2010;106(4):489—92. DOI:10.1111/j.1464-410X.2009.09147.x.; Волкова М.И., Скворцов И.Я., Климов А.В. и др. Влияние объема хирургического вмешательства на функциональные результаты и кардиоспецифическую выживаемость у больных клинически локализованным раком почки. Онкоурология 2014;(3):22—30.; Thompson R.H., Frank I., Lohse C.M. et al. The impact of ischemia time during open nephron sparing surgery on solitary kidneys: a multi-institutional study. J Urol 2007;177(2):471 —6. DOI:10.1016/j.juro.2006.09.036.; Zhang Z., Ercole C.E., Remer E.M. et al. Analysis of atrophy after clamped partial nephrectomy and potential impact of ischemia. Urology 2015;85(6):1417—22. DOI:10.1016/j.urology.2015.02.040.; Baumert H., Ballaro A., Shah N. et al. Reducing warm ischaemia time during laparoscopic partial nephrectomy: a prospective comparison of two renal closure techniques. Eur Urol 2007;52(4):1164—9. DOI:10.1016/j.eururo.2007.03.060.; Алексеев Б.Я., Андрианов А.Н., Кал-пинский А.С. и др. Лапароскопическая резекция почки с применением радиочастотной термоабляции: отдаленные онкологические и функциональные результаты. Медицинский альманах 2015;2(37):35—41.; Gill I., Eisenberg M., Aron M. et al. “Zero ischemia” partial nephrectomy: novel laparoscopic and robotic technique. Eur Urol 2011;59(1):128—34. DOI:10.1016/j.eururo.2010.10.002.; Lotan Y., Gettman M.T., Lindberg G. et al. Laparoscopic partial nephrectomy using holmium laser in a porcine model. JSLS 2004;8(1):51-5.; Thomas A., Smyth L., Hennessey D. et al. Zero ischemia laparoscopic partial thulium laser nephrectomy. J Endourol 2013;27(11):1366—70. DOI:10.1089/end.2012.0527.; Bui M.H., Breda A., Gui D. et al. Less smoke and minimal tissue carbonization using a thulium laser for laparoscopic partial nephrectomy without hilar clamping in a porcine model. J Endourol 2007;21(9):1107—11. DOI:10.1089/end.2006.0440.; Moinzadeh A., Gill I.S., Rubenstein M. et al. Potassium-titanyl-phosphate laser laparoscopic partial nephrectomy without hilar clamping in the survival calf model. J Urol 2005;174(3):1110—4. DOI:10.1097/01.ju.0000168620.36893.6c.; Gruschwitz T., Stein R., Schubert J., Wunderlich H. Laser-supported partial nephrectomy for renal cell carcinoma. Urology 2008;71(2):334-6. DOI:10.1016/j.urology.2007.09.060.; Kutikov A., Uzzo R.G. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 2009;182(3):844-53. DOI:10.1016/j.juro.2009.05.035.; Аляев Ю.Г., Сирота Е.С., Рапопорт Л.М. и др. Сравнение значимости шкал нефрометрической оценки RENAL, PADUA, С-index для прогноза сложности лапароскопической резекции почки. Онкоурология 2018;14(1):36—46. DOI:10.17650/1726-9776-2018-14-1-36-46.; Drerup M., Magdy A., Hager M. et al. Non-ischemic laparoscopic partial nephrectomy using 1318-nm diode laser for small exophytic renal tumors. BMC Urology 2018;18(99):1-6. DOI:10.1186/s12894-018-0405-9.; Xia S.J., Zhuo J., Sun X.W. et al. Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 2008;53(2):382-9. DOI:10.1016/j.eururo.2007.05.019.; https://oncourology.abvpress.ru/oncur/article/view/1019

الاتاحة: https://oncourology.abvpress.ru/oncur/article/view/1019
https://doi.org/10.17650/1726-9776-2020-16-2-46-51

المؤلفون: L. I. Shats, B. V. Kondratiev, M. B. Belogurova, Л. И. Шац, Б. В. Кондратьев, М. Б. Белогурова

المصدر: Russian Journal of Pediatric Hematology and Oncology; Том 7, № 3 (2020); 119-124 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 7, № 3 (2020); 119-124 ; 2413-5496 ; 2311-1267 ; 10.21682/2311-1267-2020-7-3

مصطلحات موضوعية: опухоль почки, nephroblastomatosis, nephrogenic rests, renal tumour, Wilms tumour, нефробластома, нефробластоматоз, нефрогенные остатки

وصف الملف: application/pdf

Relation: https://journal.nodgo.org/jour/article/view/635/581; Beckwith J.B., Kiviat N.B., Bonadio J.F. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms’ tumor. Pediatr Pathol 1990;10(1–2):1–36. https://doi.org/10.3109/15513819009067094.; Beckwith J.B. Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations. Am J Med Genet 1998;79:268–73. doi:10.1002/(sici)10968628(19981002)79:4%3C268::aid-ajmg7%3E3.0.co;2-i.; Beckwith J.B. Precursor lesions of Wilms tumor: clinical and biological implications. Med Pediatr Oncol 1993;21(3):158–68. doi:10.1002/mpo.2950210303.; Breslow N.E., Beckwith J.B., Perlman E.J., Reeve A.E. Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor. Pediatr Blood Cancer 2006;47:260–7. doi:10.1002/pbc.20891.; Fukuzawa R., Reeve A.E. Molecular pathology and epidemiology of nephrogenic rests and Wilms tumors. J Pediatr Hematol Oncol 2007;29(9):589–94. doi:10.1097/01.mph.0000212981.67114.; Perlman E.J., Faria P., Soares A., Hoffer F., Sredni S., Ritchey M., Shamberger R.C., Green D., Beckwith J.B. Hyperplastic perilobar nephroblastomatosis: long term survival of 52 patients. Pediatr Blood Cancer 2006;26:203–21. doi:10.1002/pbc.20386.; Heller M.T., Haarer K.A., Thomas E., Thaete F.L. Neoplastic and proliferative disorders of the perinephric space. Clin Rad 2012;67:e31–41. doi:10.1016/j.crad.2012.03.015.; Vujanić G.M., Apps J.R., Moroz V., Ceroni F., Williams R.D., Sebire N.J., Pritchard-Jones K. Nephrogenic rests in Wilms tumors treated with preoperative chemotherapy: The UK SIOP Wilms Tumor 2001 Trial experience. Pediatr Blood Сancer 2017;64:e26547. doi:10.1002/pbc.26547.; Качанов Д.Ю., Митрофанова А.М., Щербаков А.П., Шаманская Т.В., Меркулов Н.Н., Терещенко Г.В., Варфоломеева С.Р. Перилобарные остатки нефрогенной стромы гиперпластического типа левой почки: трудности дифференциальной диагностики с нефробластомой. Российский журнал детской гематологии и онкологии 2016;3(1):67–9. doi:10.17650/2311-1267-2016-3-1-67-69.; Kim S.H. Radiology Illustrated Uroradiology, 2012. P. 342. doi:10.1007/978-3-642-05322-1.; Grattan-Smith J.D. Nephroblastomatosis: imaging challenges. Pediatr Radiol 2011;41(Suppl 1):198. doi:10.1007/s00247-011-1997-3.; Lowe L.H., Isuani B.H., Heller R.M., Stein S.M., Johnson J.E., Navarro O.M., Hernanz-Schulman M. Pediatric renal masses: Wilms tumor and beyond. Radiographics 2000;20(6):1585–603 doi:10.1148/radiographics.20.6.g00nv051585.; Coppes M.J., Arnold M., Beckwith J.B., Ritchey M.L., D’Angio G.J., Green D.M., Breslow N.E. Factors affecting the risk of contralateral Wilms tumor development. Cancer 1999;85:1616–25. doi:10.1002/(sici)1097-0142(19990401)85:73.0.co;2-4.; Ortiz M.V., Fernandez-Ledon S., Ramaswamy K., Shukla N.N., Kobos R., Heaton T.E., LaQuaglia M.P. Maintenance chemotherapy to reduce the risk of a metachronous Wilms tumor in children with bilateral nephroblastomatosis. Pediatr Blood Cancer 2019;66:e27500. doi:10.1002/pbc.27500.; https://journal.nodgo.org/jour/article/view/635

الاتاحة: https://journal.nodgo.org/jour/article/view/635
https://doi.org/10.21682/2311-1267-2020-7-3-119-124

المؤلفون: A. Karnin D., A. Kostin A., S. Stepanov O., N. Vorobyev V., P. Bespalov D., V. Dimitrov O., А. Каприн Д., А. Костин А., С. Степанов О., Н. Воробьев В., П. Беспалов Д., В. Димитров О.

المصدر: Research and Practical Medicine Journal; Том 6, № 1 (2019); 50-59 ; Исследования и практика в медицине; Том 6, № 1 (2019); 50-59 ; 2410-1893 ; 2409-2231 ; 10.17709/2409-2231-2019-6-1

مصطلحات موضوعية: kidney tumor, intraoperative ultrasound, kidney resection, complications, RENAL scale, опухоль почки, интраоперационное ультразвуковое исследование, резекция почки, осложнения, шкала RENAL

وصف الملف: application/pdf

Relation: https://www.rpmj.ru/rpmj/article/view/358/284; Гусев А. А., Евсеев С. В., Ахохов З. М. Изменение биологии почечно-клеточного рака: Сравнение двух декад в одном лечебном центре. Вестник урологии. 2017;5 (1):20–5. DOI:10.21886/2306–6424–2017–5-1–20–25; Petejova N, Martinek A. Renal cell carcinoma: Review of etiology, pathophysiology and risk factors. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Jun;160 (2):183–94. DOI:10.5507/bp.2015.050; Wagener N. Renal cell carcinoma in older and geriatric patients. Urologe A. 2017 Aug;56 (8):1019–1024. DOI:10.1007/s00120–017–0396–2.; Ивахно К. Ю., Карнаух П. А. Использование интраоперационного УЗИ при органосохраняющем лечении рака почки. Медицинский вестник Башкортостана. 2011;6 (2):253–5.; Pannala R, Hallberg-Wallace KM, Smith AL, Nassar A, Zhang J, Zarka M, Reynolds JP, Chen L. Endoscopic ultrasound-guided fine needle aspiration cytology of metastatic renal cell carcinoma to the pancreas: A multi-center experience. Cytojournal. 2016 Oct 13;13:24. eCollection 2016. DOI:10.4103/1742–6413.192191; Doerfler A, Cerantola Y, Meuwly JY, Lhermitte B, Bensadoun H, Jichlinski P. Ex vivo ultrasound control of resection margins during partial nephrectomy. J Urol. 2011 Dec;186 (6):2188–93. DOI:10.1016/j.juro.2011.07.100.; Sorokin I, Canvasser N, Margulis V, Lotan Y, Raj G, Sagalowsky A, Gahan JC, Cadeddu JA. The Utility of Axial Abdominal Imaging after Partial Nephrectomy for T1 Renal Cell Carcinoma Surveillance. J Urol. 2017 Nov;198 (5):1021–1026. DOI:10.1016/j. juro.2017.04.080; Tanimoto A, Takeuchi S, Yaegashi H, Kotani H, Kitai H, Nanjo S, et al. Recurrence of renal cell carcinoma diagnosed using contralateral adrenal biopsy with endoscopic ultrasound-guided fine-needle aspiration. Mol Clin Oncol. 2016 Apr;4 (4):537–540. DOI:10.3892/mco.2016.739; Шорманов И. С., Лось М. С., Титов К. С. Комплексная противоишемическая терапия раннего послеоперационного периода органосохраняющего оперативного лечения почечно- клеточного рака. Российский биотерапевтический журнал. 2018;17 (1):58–63.; Adams LC, Ralla B, Bender YY, Bressem K, Hamm B, Busch J, Fuller F, Makowski MR. Renal cell carcinoma with venous extension: prediction of inferior vena cava wall invasion by MRI. Cancer Imaging. 2018 May 3;18 (1):17. DOI:10.1186/s40644–018– 0150 z.; Crestani A, Rossanese M, Calandriello M, Sioletic S, Giannarini G, Ficarra V. Introduction to small renal tumours and prognostic indicators. Int J Surg. 2016 Dec;36 (Pt C):495–503. DOI:10.1016/j.ijsu.2016.03.038.; Чехоева О. А. Возможности ультразвукового исследования при диагностике опухоли почки на этапе планирования оперативного вмешательства. Медицинская визуализация. 2017;21 (3):44–52. DOI:10.24835/1607–0763–2017–3-44–52; https://www.rpmj.ru/rpmj/article/view/358

الاتاحة: https://www.rpmj.ru/rpmj/article/view/358
https://doi.org/10.17709/2409-2231-2019-6-1-5

المؤلفون: S. V. Shkodkin, Yu. B. Idashkin, S. A. Fironov, V. V. Fentisov, A. N. Udovenko, С. В. Шкодкин, Ю. Б. Идашкин, С. А. Фиронов, В. В. Фентисов, А. Н. Удовенко

المصدر: Urology Herald; Том 6, № 2 (2018); 54-61 ; Вестник урологии; Том 6, № 2 (2018); 54-61 ; 2308-6424 ; 10.21886/2308-6424-2018-6-2

مصطلحات موضوعية: опухоль почки, renal cell carcinoma, resection of the kidney, kidney tumor, почечно-клеточный рак, резекция почки

وصف الملف: application/pdf

Relation: https://www.urovest.ru/jour/article/view/206/166; Zhang M, Zhao Z, Duan X, Deng T, Cai C, Wu W, Zeng G. ParTIal versus radical nephrectomy for T1b-2N0M0 renal tumors: A propensity score matching study based on the SEER database. PLoS One. 2018;28;13(2):e0193530. DOI:10.1371/journal.pone.0193530; Marchioni M, Preisser F, Bandini M, Nazzani S, Tian Z, Kapoor A, Cindolo L, Abdollah F, Tilki D, BriganTIA, Montorsi F, Shariat SF, Schips L, Karakiewicz PI. Comparison of ParTIal Versus Radical Nephrectomy Eff ect on Othercause Mortality, Cancer-specifi c Mortality, and 30-day Mortality in PaTIents Older Than 75 Years. Eur Urol Focus. 2018;2.pii:S2405-4569(18)30008-7. DOI:10.1016/j.euf.2018.01.007; Мосоян М.С., Аль-Шукри С.Х., Есаян А.М., Каюков И.Г. Ранние клинико-функциональные показатели у больных раком почки, перенесших резекцию почки или радикальную нефрэктомию. Нефрология. 2012;16:4:100-104.; Пучков К.В., Филимонов В.Б., Крапивин А.А., Васин Р.В., Васин И.В. Хирургическое лечение рака почки сегодня: лапароскопическая радикальная нефрэктомия и резекция почки. Урология. 2008;1:47-53.; Павлов А.Ю., Кравцов И.Б. Функциональное состояние почек и течение послеоперационного периода при резекции почки по поводу рака. Справочник врача общей практики. 2013;7:64-69.; Bertolo R, Garisto J, Dagenais J, Agudelo J, Armanyous S, Lioudis M, Kaouk J. Cold versus warm ischemia robotassisted parTIal nephrectomy: Comparison of funcTIonal outcomes in propensity-score matched “at risk” paTIents. J Endourol. 2018;21. DOI:10.1089/end.2018.0383; Arora S, Rogers C. ParTIal Nephrectomy in Central Renal Tumors. J Endourol. 2018;32(S1):63-S67. DOI:10.1089/end.2018.0046; Serni S, ViƩ ori G, Frizzi J, Mari A, Siena G, Lapini A, Carini M, Minervini A. Simple enucleaTIon for the treatment of highly complex renal tumors: PerioperaTIve, funcTIonal and oncological results. Eur J Surg Oncol. 2015;41(7):934- 40. DOI:10.1016/j.ejso.2015.02.019; Calaway AC, Gondim DD, Flack CK, Jacob JM, Idrees MT, Boris RS. Anatomic comparison of tradiTIonal and enucleaTIon parTIal nephrectomy specimens. Urol Oncol. 2017;35(5):221-226. DOI:10.1016/j.urolonc.2016.12.005; Mari A, Morselli S, Sessa F, Campi R, Di Maida F, Greco I, Siena G, Tuccio A, ViƩ ori G, Serni S, Carini M, Minervini A. Impact of the off -clamp endoscopic robot-assisted simple enucleaTIon (ERASE) of clinical T1 renal tumors on the postoperaTIve renal funcTIon: Results from a matchedpair comparison. Eur J Surg Oncol. 2018;44(6):853-858. DOI:10.1016/j.ejso.2018.01.093; Huang J, Zhang J, Wang Y, Kong W, Xue W, Liu D, Chen Y, Huang Y. Comparing Zero Ischemia Laparoscopic Radio Frequency Ablation Assisted Tumor Enucleationand Laparoscopic Partial Nephrectomy for Clinical T1a Renal Tumor: A Randomized Clinical Trial. J Urol. 2016;195(6):1677-83. DOI:10.1016/j.juro.2015.12.115; Minervini A, Campi R, Sessa F, Derweesh I, Kaouk JH, Mari A, Rha KH, Sessa M, Volpe A, Carini M, Uzzo RG. Positive surgical margins and local recurrence after simple enucleation and standard partialnephrectomy for malignant renal tumors: systematic review of the literature and meta-analysis of prevalence. Minerva Urol Nefrol. 2017;69(6):523-538. DOI:10.23736/S0393-2249.17.02864-8; Wang L, Hughes I, Snarskis C, Alvarez H, Feng J, Gupta GN, Picken MM. Tumor enucleation specimens of small renal tumors more frequently have a positive surgical margin than partial nephrectomy specimens, but this is not associated with local tumor recurrence. Virchows Arch. 2017;470(1):55-61. DOI:10.1007/s00428-016-2031-9; Шкодкин С.В., Татаринцев А.М., Идашкин Ю.Б., Любушкин А.В., Фиронов С.А. Экстракорпоральная резекция почки: а стоит ли? Урология. 2016;3:62-69.; https://www.urovest.ru/jour/article/view/206

الاتاحة: https://www.urovest.ru/jour/article/view/206
https://doi.org/10.21886/2308-6424-2018-6-2-54-61

المؤلفون: Akopyan, G. N., Alyaev, Ju. G., Pshihachev, A. M., Акопян, Г. Н., Аляев, Ю. Г., Пшихачев, А. М.

مصطلحات موضوعية: PERCUTANEOUS NEPHROLITHOTOMY, KIDNEY TUMOR, THE COMBINATION OF KIDNEY CANCER AND ICD, PCNL FOR RENAL TUMOR, ПЕРКУТАННАЯ НЕФРОЛИТОТОМИЯ, ОПУХОЛЬ ПОЧКИ, СОЧЕТАНИЕ ОПУХОЛИ ПОЧКИ И МКБ, ПЕРКУТАННАЯ НЕФРОЛИТОТОМИЯ ПРИ ОПУХОЛИ ПОЧКИ

وصف الملف: application/pdf

Relation: Уральский медицинский журнал. 2017. Т. 146, № 2.; Акопян, Г. Н. Перкутанная нефролитотомия при ипсилатеральной опухоли почки / Г. Н. Акопян, Ю. Г. Аляев, А. М. Пшихачев. – Текст: электронный // Уральский медицинский журнал. - 2017. – T. 146, № 2. – С. 159-163.; http://elib.usma.ru/handle/usma/13658

الاتاحة: http://elib.usma.ru/handle/usma/13658

المؤلفون: B. Alekseev Ya., I. Shevchuk M., G. Efremov D., S. Samoylova I., Б. Алексеев Я., И. Шевчук М., Геннадий Ефремов Дмитриевич, С. Самойлова И.

المصدر: Cancer Urology; Том 13, № 3 (2017); 34-38 ; Онкоурология; Том 13, № 3 (2017); 34-38 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2017-13-3

مصطلحات موضوعية: multilocular cystic renal neoplasia of low malignant potential, tumor of the kidney, prognosis, stage, мультилокулярная кистозная почечная неоплазия низкого злокачественного потенциала, опухоль почки, прогноз, стадия

وصف الملف: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/656/692; Злокачественные новообразования в России в 2015 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИРЦ» Минздрава России, 2016. 250 с. [Malignant tumors in Russia in 2015 (morbidity and fatality). Eds.: А.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMIRTS” Minzdrava Rossii, 2016. 250 p. (In Russ.)].; Ferlay J., Steliarova-Foucher E., Lortet-Tieulent J. et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013;49(6):1374–403. DOI:10.1016/j.ejca.2012.12.027. PMID: 23485231.; Lopez-Beltran A., Scarpelli M., Montironi R., Kirkali Z. 2004 WHO classification of the renal tumors of the adults. Eur Urol 2006;49(5):798–805. DOI:10.1016/j.eururo.2005.11.035. PMID: 16442207.; Bhatt J.R., Jewett M.A., Richard P.O. et al. Multilocular cystic renal cell carcinoma: pathological T staging makes no difference to favorable outcomes and should be reclassified. J Urol 2016;196(5):1350–5. DOI:10.1016/j.juro.2016.05.118. PMID: 27341751.; Li T., Chen J., Jiang Y. et al. Multilocular cystic renal cell neoplasm of low malignant potential: a series of 76 cases. Clin Genitourin Cancer 2016;14(6):553–7. DOI:10.1016/j.clgc.2016.03.017. PMID: 27108004.; Mazzucchelli R., Scarpelli M., Montironi R. et al. Multilocular cystic renal cell neoplasms of low malignant potential. Anal Quant Cytopathol Histpathol 2012;34(5):235–8. PMID: 23301382.; Srigley J.R., Delahunt B., Eble J.N. et al. The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia. Am J Surg Pathol 2013;37(10):1469–89. DOI:10.1097/PAS.0b013e318299f2d1. PMID: 24025519.; Montironi R., Lopez-Beltran A., Cheng L., Scarpelli M. Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects. Eur Urol 2013;63:400–1.; Kuroda N., Ohe C., Mikami S. et al. Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 2012;27(8):969–74. DOI:10.14670/HH-27.969. PMID: 22763870.; You D., Shim M., Jeong I.G. et al. Multilocular cystic renal cell carcinoma: clinicopathological features and preoperative prediction using multiphase computed tomography. BJU Int 2011;108(9):1444–4. DOI:10.1111/j.1464-410X.2011.10247.x. PMID: 21722289.; Israel G.M., Hindman N., Bosniak M.A. et al. Evaluation of cystic renal masses; comparison of CT and MR imaging by using the Bosniak classification system. Radiology 2004;231(2):365–71. DOI:10.1148/radiol.2312031025. PMID: 15128983.; Pedersen J.F., Emamian S.A., Nielsen M.B. Simple renal cyst: relations to age and arterial blood pressure. Br J Radiol 1993;66(787):581–4. DOI:10.1259/0007-1285-66-787-581. PMID: 8374720.; Gong K., Zhang N., He Z. et al. Multilocular cystic renal cell carcinoma: an experience of clinical management for 31 cases. J Cancer Res Clin Oncol 2008;134(4):433–7. DOI:10.1007/s00432-007-0302-1. PMID: 17846788.; Halat S., Eble J.N., Grignon D.J. et al. Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinoma. Mod Pathol 2010;23(7):931–6. DOI:10.1038/modpathol.2010.78. PMID: 20348877.; Jhaveri K., Gupta P., Elmi A. et al. Cystic renal cell carcinomas: do they grow, metastasize, or recur? AJR Am J Roentgenol 2013;201(2): 292–6. DOI:10.2214/AJR.12.9414. PMID: 23883243.; Webster W.S., Thompson R.H., Cheville J.C. et al. Surgical resection provides excellent outcomes for patients with cystic clear cell renal cell carcinoma. Urology 2007;70(5):900–4. DOI:10.1016/j.urology.2007.05.029. PMID: 18068445.; Koga S., Nishikida M., Hayashi T. et al. Outcome of surgery in cystic renal cell carcinoma. Urology 2000;56(1):67–70. PMID: 10869626.; https://oncourology.abvpress.ru/oncur/article/view/656

الاتاحة: https://oncourology.abvpress.ru/oncur/article/view/656
https://doi.org/10.17650/1726-9776-2017-13-3-34-38

المؤلفون: D. S. Mikhaylenko, M. V. Teleshova, D. V. Perepechin, G D. Efremov, D. Yu. Kachanov, E. V. Raykina, V. O. Bobrynina, S. G. Lavrina, A. M. Mitrofanova, D. M. Konovalov, S. R. Varfolomeeva, B. Ya. Alekseev, Д. С. Михайленко, М. В. Телешова, Д. В. Перепечин, Г. Д. Ефремов, Д. Ю. Качанов, Е. В. Райкина, В. О. Бобрынина, С. Г. Лаврина, А. М. Митрофанова, Д. М. Коновалов, С. Р. Варфоломеева, Б. Я. Алексеев

المصدر: Cancer Urology; Том 13, № 2 (2017); 14-19 ; Онкоурология; Том 13, № 2 (2017); 14-19 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2017-13-2

مصطلحات موضوعية: опухоль почки, SMARCB1 gene, nonsense-mutation, sequencing, renal tumor, ген SMARCB1, нонсенс-мутация, секвенирование

وصف الملف: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/630/652; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/630/368; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/630/369; Van den Heuvel-Eibrink M.M., van Tinteren H., Rehorst H. et al. Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: a report of the SIOP renal tumour study group. Pediatr Blood Cancer 2011;56(5):733–7. DOI:10.1002/pbc.22922. PMID: 21370404.; Heck J.E., Lombardi C.A., Cockburn M. et al. Epidemiology of rhabdoid tumors of early childhood. Pediatr Blood Cancer 2013;60(1):77–81. DOI:10.1002/pbc.24141. PMID: 22434719.; Fernandez C., Bouvier C., Sevenet N. et al. Congenital disseminated malignant rhabdoid tumor and cerebellar tumor mimicking medulloblastoma in monozygotic twins. pathologic and molecular diagnosis. Am J Surg Pathol 2002;26(2):266–70. PMID: 11812951.; Kieran M.W., Roberts C.W., Chi S.N. et al. Absence of oncogenic canonical pathway mutations in aggressive pediatric rhabdoid tumors. Pediatr Blood Cancer 2012;59(7):1155–7. DOI:10.1002/pbc.24315. PMID: 22997201.; Witkowski L., Lalonde E., Zhang J. et al. Familial rhabdoid tumor “avant la lettre” – from pathology review to exome sequencing and back again. J Pathol 2013;231(1):35–43. DOI:10.1002/path.4225. PMID: 23775540.; Schneppenheim R., Fruhwald M.C., Gesk S. et al. Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. Am J Hum Genet 2010;86(2):279–84. DOI:10.1016/j.ajhg.2010.01.013. PMID: 20137775.; Biegel J.A., Tan L., Zhang F. et al. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 2002;8(11):3461–7. PMID: 12429635.; Bourdeaut F., Lequin D., Brugieres L. et al. Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor. Clin Cancer Res 2011;17(1):31–8. DOI:10.1158/1078-0432.CCR-10-1795. PMID: 21208904.; Teplick A., Kowalski M., Biegel J.A., Nichols K.E. Educational paper: screening in cancer predisposition syndromes: guidelines for the general pediatrician. Eur J Pediatr 2011;170(3):285–94. DOI:10.1007/s00431-010-1377-2. PMID: 21210147.; Gigante L., Paganini I., Frontali M. et al. Rhabdoid tumor predisposition syndrome caused by SMARCB1constitutional deletion: prenatal detection of new case of recurrence in siblings due to gonadal mosaicism. Fam Cancer 2016;15(1):123–6. DOI:10.1007/s10689-015-9836-6. PMID: 26342593.; Biegel J.A., Busse T.M., Weissman B.E. SWI/SNF chromatin remodeling complexes and cancer. Am J Med Genet C Semin Med Genet 2014;166C(3):350–66. DOI:10.1002/ajmg.c.31410. PMID: 25169151.; Johansson G., Andersson U., Melin B. Recent developments in brain tumor predisposing syndroms. Acta Oncol 2016;55(4):401–11. DOI:10.3109/0284186X.2015.1107190. PMID: 26634384.; Bartelheim K., Sumerauer D., Behrends U. et al. Clinical and genetic features of rhabdoid tumors of the heart registered with the European Rhabdoid Registry (EU-RHAB). Cancer Genet 2014;207(9):379–83. DOI:10.1016/j.cancergen.2014.04.005. PMID: 24972932.; Sredni S.T., Tomita T. Rhabdoid tumor predisposition syndrome. Pediatr Dev Pathol 2015;18(1):49–58. DOI:10.2350/14-07-1531-MISC.1. PMID: 25494491.; Dagar V., Chow C.W., Ashley D.M., Algar E.M. Rapid detection of SMARCB1 sequence variation using high resolution melting. BMC Cancer 2009;9:437. DOI:10.1186/1471-2407-9-437. PMID: 20003390.; Fujisawa H., Takabatake Y., Fukusato T. et al. Molecular analysis of the rhabdoid predisposition syndrome in a child: a novel germline hSNF5/INI1 mutation and absence of c-myc amplification. J Neurooncol 2003;63(3):257–62. PMID: 12892231.; Hasselblatt M., Isken S., Linge A. et al. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors. Genes Chromosomes Cancer 2013;52(2):185–90. DOI:10.1002/gcc.22018. PMID: 23074045.; Eaton K.W., Tooke L.S., Wainwright L.M. et al. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer 2011;56(1):7–15. DOI:10.1002/pbc.22831. PMID: 21108436.; Sevenet N., Lellouch-Tubiana A., Schofield D. et al. Spectrum of hSNF5/ INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum Mol Genet 1999;8(13):2359–68. PMID: 10556283.; Jackson E.M., Sievert A.J., Gai X. et al. Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors. Clin Cancer Res 2009;15(6):1923–30. DOI:10.1158/1078-0432.CCR-08-2091. PMID: 19276269.; Kim K.H., Roberts C.W. Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth. Cancer Genet 2014;207(9):365–72. DOI:10.1016/j.cancergen.2014.04.004. PMID: 24853101.; https://oncourology.abvpress.ru/oncur/article/view/630

الاتاحة: https://oncourology.abvpress.ru/oncur/article/view/630
https://doi.org/10.17650/1726-9776-2017-13-2-14-19

المؤلفون: Zyryanov, A. V., Ponomarev, А. V., Juravlev, О. V., Surikov, A. S., Зырянов, А. В., Пономарев, А. В., Журавлев, О. В., Суриков, А. С.

مصطلحات موضوعية: TUMOR OF THE KIDNEY, ANATOMIC FEATURES OF THE TUMOR, ROBOT-ASSISTED PARTIAL NEPHRECTOMY, R. E. N. A. L, OPERATION TIME, HEAT ISCHEMIA OF THE KIDNEY, VOLUME OF BLOOD LOSS, ОПУХОЛЬ ПОЧКИ, АНАТОМИЧЕСКИЕ ХАРАКТЕРИСТИКИ ОПУХОЛИ, РОБОТ-АССИСТИРОВАННАЯ РЕЗЕКЦИЯ ПОЧКИ, R.E.N.A.L, ВРЕМЯ ОПЕРАЦИИ, ТЕПЛОВАЯ ИШЕМИЯ ПОЧКИ, ОБЪЕМ КРОВОПОТЕРИ

وصف الملف: application/pdf

Relation: Уральский медицинский журнал. 2016. T. 134, № 1.; Робот-ассистированная резекция почки в зависимости от анатомической сложности расположения опухоли / А. В. Зырянов, А. В. Пономарев, О. В. Журавлев, А. С. Суриков. – Текст: электронный // Уральский медицинский журнал. - 2016. – T. 134, № 1. – С. 14-18.; http://elib.usma.ru/handle/usma/13864

الاتاحة: http://elib.usma.ru/handle/usma/13864

المؤلفون: АЛЯЕВ Ю.Г., СОРОКИН Н.И., КОНДРАШИН С.А., ШПОТЬ Е.В., СИРОТА Е.С.

مصطلحات موضوعية: ОПУХОЛЬ ПОЧКИ,СУПЕРСЕЛЕКТИВНАЯ ЭМБОЛИЗАЦИЯ ПОЧЕЧНЫХ СОСУДОВ,РЕЗЕКЦИЯ ПОЧКИ,KIDNEY TUMOR,RENAL VASCULAR EMBOLIZATION SUPERSELECTIVE,PARTIAL NEPHRECTOMY

وصف الملف: text/html

الاتاحة: http://cyberleninka.ru/article/n/superselektivnaya-embolizatsiya-sosudov-pitayuschih-opuhol-pered-rezektsiey-pochki
http://cyberleninka.ru/article_covers/16976800.png

المؤلفون: I. E. Mamaev, A. Yu. Seroukhov, K. I. Glinin, E. A. Pronkin, И. Э. Мамаев, А. Ю. Сероухов, К. И. Глинин, Е. А. Пронкин

المصدر: Cancer Urology; Том 11, № 3 (2015); 46-49 ; Онкоурология; Том 11, № 3 (2015); 46-49 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2015-11-3

مصطلحات موضوعية: биопсия почки, urothelial cancer of the kidney, urothelial carcinoma of the kidney, kidney tumor, leukemoid reaction, computed tomography, Bellini duct carcinoma, differential diagnosis, kidney biopsy, уротелиальный рак почки, уротелиальная карцинома почки, опухоль почки, лейкемоидная реакция, компьютерная томография, протоковая карцинома Беллини, дифференциальная диагностика

وصف الملف: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/487/453; Дворецкий Л.И. Паранеопластические синдромы. Consilium medicum 2003;3(3). [Dvoretckii L.I. Paraneoplastic syndromes. Consilium medicum 2003;3(3). (In Russ.)].; Sacco E., Pinto F., Sasso F. et al. Paraneoplastic syndromes in patients with urological malignancies. Urol Int 2009;83: 1–11.; Palapattu G.S., Kristo B., Rajfer J. Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma. Rev Urol 2002;4(4):163–70.; Izard J.P., Gore J.L., Mostaghel E.A. et al. Persistent, unexplained leukocytosis is a paraneoplastic syndrome associated with a poor prognosis in patients with urothelial carcinoma. Clin Genitourin Cancer 2015;13(4):e253-8. doi:10.1016/j. clgc.2015.02.008.; Francisco A. Perez, Corinne L. Fligner, Evan Y. Yu, Rapid clinical deterioration and leukemoid reaction after treatment of urothelial carcinoma of the bladder: possible effect of granulocyte colony-stimulating factor. JCO 2009;1:e215-e217.; Suo A., Abbas T. Paraneoplastic leukemoid reaction in a patient with urothelial carcinoma: a case report. CRCM 2014;3:249–52.; Zell J.A., Chang J.C. Neoplastic fever: a neglected paraneoplastic syndrome. SCC 2005;13(11):870–7.; Jung J.S., Lee S.M., Kim H.J. et al. A case of septic pulmonary embolism associated with renal abscess mimicking pulmonary metastases of renal malignancy. Ann Nucl Med 2014; 28(4): 381–5.; Penel N., Fournier C., Degardin M. et al. Fever and solid tumor: diagnostic value of procalcitonin and C-reactive protein. Rev Med Interne 2001;22(8): 706–14.; https://oncourology.abvpress.ru/oncur/article/view/487

الاتاحة: https://oncourology.abvpress.ru/oncur/article/view/487
https://doi.org/10.17650/1726-9776-2015-11-3-46-49